HomeCRNX • NASDAQ
Crinetics Pharmaceuticals Inc
Follow
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 28.18M | 65.00% |
Net income | -80.60M | -34.11% |
Net profit margin | — | — |
Earnings per share | -0.88 | 2.22% |
EBITDA | -93.96M | -50.58% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.35B | 142.42% |
Total assets | 1.43B | 125.79% |
Total liabilities | 109.79M | 14.07% |
Total equity | 1.32B | — |
Shares outstanding | 93.05M | — |
Price to book | 2.46 | — |
Return on assets | -19.97% | — |
Return on capital | -20.94% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -80.60M | -34.11% |
Cash from operations | -64.67M | -67.92% |
Cash from investing | -542.09M | -520.89% |
Cash from financing | 554.04M | 1,360.88% |
Net change in cash | -52.72M | 40.02% |
Free cash flow | -40.63M | -109.28% |
Previous close
$35.04
Day range
$34.90 - $35.63
Year range
$31.84 - $62.53
Market cap
3.30B USD
Avg Volume
898.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Nov 18, 2008
Website
Employees
437
